CHG-2021-0244

Facility Change for Neprilozone. Labeling Change for Neprilozone — routine update. Impacts 3 markets and 1 variations.

Change Number
CHG-2021-0244
Type
Facility Change
Product
Neprilozone
Status
Draft
Owner
Lieselotte van der Berg
Initiated
2022-04-15
Description

Labeling Change for Neprilozone — routine update

Impacted Markets (3)
EU — European UnionKR — South KoreaIN — India
Impacted Modules
4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved